SPATA31A3
gene geneOn this page
Also known as OTTHUMG00000013164DKFZp434B204
Summary
SPATA31A3 (SPATA31 subfamily A member 3, HGNC:32003) is a protein-coding gene on chromosome 9q21.11, encoding Spermatogenesis-associated protein 31A3 (Q5VYP0). May play a role in spermatogenesis.
Predicted to be involved in cell differentiation and spermatogenesis. Predicted to be located in membrane.
Source: NCBI Gene 727830 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 254 total
- MANE Select transcript:
NM_001083124
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:32003 |
| Approved symbol | SPATA31A3 |
| Name | SPATA31 subfamily A member 3 |
| Location | 9q21.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | OTTHUMG00000013164, DKFZp434B204 |
| Ensembl gene | ENSG00000275969 |
| Ensembl biotype | protein_coding |
| Entrez | 727830 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000428649
RefSeq mRNA: 1 — MANE Select: NM_001083124
NM_001083124
CCDS: CCDS78400
Canonical transcript exons
ENST00000428649 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001645381 | 66991074 | 66991131 |
| ENSE00001709331 | 66986304 | 66990189 |
| ENSE00003750472 | 66990445 | 66990505 |
| ENSE00003978258 | 66992333 | 66992550 |
Expression profiles
Bgee: expression breadth tissue_specific, 5 present calls, max score 62.13.
Top tissues by expression
128 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right testis | UBERON:0004534 | 62.13 | gold quality |
| left testis | UBERON:0004533 | 62.08 | gold quality |
| testis | UBERON:0000473 | 61.81 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 34.95 | gold quality |
| muscle tissue | UBERON:0002385 | 33.23 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 33.16 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| prefrontal cortex | UBERON:0000451 | 30.26 | gold quality |
| primary visual cortex | UBERON:0002436 | 30.06 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| right uterine tube | UBERON:0001302 | 29.75 | gold quality |
| liver | UBERON:0002107 | 29.69 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 29.35 | gold quality |
| monocyte | CL:0000576 | 28.17 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| leukocyte | CL:0000738 | 28.11 | gold quality |
| fallopian tube | UBERON:0003889 | 27.93 | silver quality |
| blood | UBERON:0000178 | 27.86 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| uterine cervix | UBERON:0000002 | 26.11 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.99 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
23 targeting SPATA31A3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-4747-5P | 100.00 | 67.90 | 2681 |
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548D-3P | 99.87 | 70.67 | 4362 |
| HSA-MIR-548BB-3P | 99.86 | 70.58 | 4354 |
| HSA-MIR-548AC | 99.84 | 70.77 | 4351 |
| HSA-MIR-548H-3P | 99.84 | 70.80 | 4349 |
| HSA-MIR-548Z | 99.84 | 70.80 | 4349 |
| HSA-MIR-6505-5P | 99.73 | 69.25 | 1595 |
| HSA-MIR-6833-5P | 99.50 | 68.93 | 1161 |
| HSA-MIR-519A-2-5P | 98.78 | 71.74 | 1401 |
| HSA-MIR-520B-5P | 98.78 | 71.74 | 1401 |
| HSA-MIR-4752 | 98.71 | 68.04 | 833 |
| HSA-MIR-4684-5P | 98.29 | 67.99 | 1650 |
| HSA-MIR-6810-5P | 98.29 | 66.21 | 975 |
| HSA-MIR-7113-5P | 97.88 | 67.33 | 1735 |
| HSA-MIR-376C-3P | 97.63 | 68.88 | 1263 |
| HSA-MIR-3190-3P | 97.61 | 66.95 | 1406 |
| HSA-MIR-5586-3P | 95.51 | 67.00 | 805 |
Literature-anchored findings (GeneRIF, showing 1)
- Novel biomarkers for primary biliary cholangitis to improve diagnosis and understand underlying regulatory mechanisms. (PMID:31033124)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Spata31 | ENSMUSG00000056223 |
| rattus_norvegicus | Spata31 | ENSRNOG00000018202 |
Paralogs (13): SPATA31C2 (ENSG00000177910), SPATA31E1 (ENSG00000177992), SPATA31A6 (ENSG00000185775), SPATA31D3 (ENSG00000186788), SPATA31F3 (ENSG00000187791), SPATA31D4 (ENSG00000189357), SPATA31A1 (ENSG00000204849), SPATA31F1 (ENSG00000205108), SPATA31D1 (ENSG00000214929), SPATA31C1 (ENSG00000230246), (ENSG00000251545), SPATA31A7 (ENSG00000276040), SPATA31A5 (ENSG00000276581)
Protein
Protein identifiers
Spermatogenesis-associated protein 31A3 — Q5VYP0 (reviewed: Q5VYP0)
Alternative names: Protein FAM75A3
All UniProt accessions (1): Q5VYP0
UniProt curated annotations — full annotation on UniProt →
Function. May play a role in spermatogenesis.
Subcellular location. Membrane.
Similarity. Belongs to the SPATA31 family.
RefSeq proteins (1): NP_001076593* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR027970 | SPATA31-like | Domain |
| IPR039509 | SPATA31 | Domain |
Pfam: PF14650, PF15371
UniProt features (18 total): region of interest 8, compositionally biased region 7, chain 1, transmembrane region 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5VYP0-F1 | 38.73 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 15 (showing top):
GOBP_MALE_GAMETE_GENERATION, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, chr9q21, MIR548D_3P, MIR548H_3P_MIR548Z, MIR548BB_3P, MIR548AC, MIR519A_2_5P_MIR520B_5P, MIR4684_5P, MIR6833_5P, MIR5586_3P, GOBP_SEXUAL_REPRODUCTION, GOBP_REPRODUCTIVE_PROCESS, GOBP_MULTICELLULAR_ORGANISMAL_REPRODUCTIVE_PROCESS
GO Biological Process (2): spermatogenesis (GO:0007283), cell differentiation (GO:0030154)
GO Molecular Function (0):
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| cellular developmental process | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
36 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SPATA31A3 | CNTNAP3B | Q96NU0 | 621 |
| SPATA31A3 | DLAT | P10515 | 348 |
| SPATA31A3 | TDRD7 | Q8NHU6 | 220 |
| SPATA31A3 | FOXE3 | Q13461 | 203 |
| SPATA31A3 | ALDH1B1 | P30837 | 202 |
| SPATA31A3 | CRYGS | P22914 | 201 |
| SPATA31A3 | FYCO1 | Q9BQS8 | 182 |
| SPATA31A3 | TRPM6 | Q9BX84 | 178 |
| SPATA31A3 | TRPV3 | Q8NET8 | 164 |
| SPATA31A3 | TRPM3 | Q9HCF6 | 164 |
| SPATA31A3 | PKD1 | P98161 | 153 |
| SPATA31A3 | TRPM4 | Q8TD43 | 152 |
| SPATA31A3 | MCOLN1 | Q9GZU1 | 151 |
| SPATA31A3 | SPATA31A6 | Q5VVP1 | 0 |
| SPATA31A3 | RELA | Q04206 | 0 |
| SPATA31A3 | PRAMEF11 | O60813 | 0 |
| SPATA31A3 | PPP1R2C | O14990 | 0 |
IntAct
0 interactions, top by confidence:
BioGRID (2): SPATA31A3 (Affinity Capture-MS), SPATA31A3 (Negative Genetic)
ESM2 similar proteins: A0A096LP49, A6NGG8, A6NNH2, B1ASB6, B4DYI2, B6VQA5, C0HKD1, C0HKD2, C0HKD3, D2J0Y4, D6RGX4, E9QAF0, P0C874, P0DKV0, Q149B8, Q3KR64, Q4R736, Q4V8B5, Q5TZJ5, Q5VU36, Q5VVP1, Q5VWK0, Q5VYM1, Q5VYP0, Q63HN1, Q658T7, Q68A65, Q6NS69, Q6NXZ1, Q6PAC4, Q6ZQQ2, Q6ZU69, Q6ZUB0, Q6ZUB1, Q7TSA6, Q80X53, Q86Y26, Q8BHP2, Q8BHW6, Q8C0D9
Diamond homologs: B4DYI2, B6VQA5, E9QAF0, P0C874, P0DKV0, Q5TZJ5, Q5VU36, Q5VVP1, Q5VYP0, Q6ZQQ2, Q6ZUB0, Q6ZUB1, Q8IWB4, C0HKD1, C0HKD2, C0HKD3, Q642A3, A6NFR6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
254 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 223 |
| Likely benign | 29 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
728 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:66991178:T:G | acceptor_gain | 1.0000 |
| 9:66990504:G:GG | acceptor_gain | 0.9900 |
| 9:66990504:GCTG:G | acceptor_gain | 0.9900 |
| 9:66990505:A:AG | acceptor_gain | 0.9900 |
| 9:66990505:AGCT:A | acceptor_gain | 0.9900 |
| 9:66991147:C:G | acceptor_gain | 0.9900 |
| 9:66991165:C:CA | acceptor_gain | 0.9900 |
| 9:66991167:C:CA | acceptor_gain | 0.9900 |
| 9:66991175:T:A | acceptor_gain | 0.9900 |
| 9:66991179:A:AG | acceptor_gain | 0.9900 |
| 9:66991179:ATCTT:A | acceptor_gain | 0.9900 |
| 9:66991183:T:A | acceptor_gain | 0.9900 |
| 9:66991184:T:G | acceptor_gain | 0.9900 |
| 9:66991185:A:AG | acceptor_gain | 0.9900 |
| 9:66992330:GTAAG:G | donor_loss | 0.9900 |
| 9:66992331:GGTA:G | donor_loss | 0.9900 |
| 9:66992332:AGGT:A | donor_loss | 0.9900 |
| 9:66992333:AAGG:A | donor_loss | 0.9900 |
| 9:66990445:GAG:G | donor_gain | 0.9800 |
| 9:66990504:GCT:G | acceptor_gain | 0.9800 |
| 9:66991149:G:C | acceptor_gain | 0.9800 |
| 9:66991166:C:CT | acceptor_gain | 0.9800 |
| 9:66991185:A:T | acceptor_gain | 0.9800 |
| 9:66991185:ATT:A | acceptor_gain | 0.9800 |
| 9:66992329:T:A | donor_loss | 0.9800 |
| 9:66992335:GAAAG:G | donor_gain | 0.9800 |
| 9:66989652:C:A | acceptor_gain | 0.9700 |
| 9:66990441:T:G | donor_loss | 0.9700 |
| 9:66990442:GTGAG:G | donor_loss | 0.9700 |
| 9:66990443:GGT:G | donor_loss | 0.9700 |
AlphaMissense
8802 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:66989250:G:C | F416L | 0.959 |
| 9:66989250:G:T | F416L | 0.959 |
| 9:66989252:A:G | F416L | 0.959 |
| 9:66989157:G:C | F447L | 0.925 |
| 9:66989157:G:T | F447L | 0.925 |
| 9:66989159:A:G | F447L | 0.925 |
| 9:66988125:G:C | F791L | 0.911 |
| 9:66988125:G:T | F791L | 0.911 |
| 9:66988127:A:G | F791L | 0.911 |
| 9:66989246:C:G | G418R | 0.896 |
| 9:66988061:A:G | W813R | 0.876 |
| 9:66988061:A:T | W813R | 0.876 |
| 9:66989249:A:G | W417R | 0.870 |
| 9:66989249:A:T | W417R | 0.870 |
| 9:66988791:A:C | F569L | 0.856 |
| 9:66988791:A:T | F569L | 0.856 |
| 9:66988793:A:G | F569L | 0.856 |
| 9:66988059:C:A | W813C | 0.849 |
| 9:66988059:C:G | W813C | 0.849 |
| 9:66989229:G:C | H423Q | 0.849 |
| 9:66989229:G:T | H423Q | 0.849 |
| 9:66987459:A:C | F1013L | 0.848 |
| 9:66987459:A:T | F1013L | 0.848 |
| 9:66987461:A:G | F1013L | 0.848 |
| 9:66989226:G:C | S424R | 0.848 |
| 9:66989226:G:T | S424R | 0.848 |
| 9:66989228:T:G | S424R | 0.848 |
| 9:66989163:G:C | F445L | 0.826 |
| 9:66989163:G:T | F445L | 0.826 |
| 9:66989165:A:G | F445L | 0.826 |
dbSNP variants (sampled 300 via entrez): RS1000516310 (9:66989957 G>A,C), RS1000547418 (9:66989625 G>A,C), RS1001391971 (9:66987473 C>A,T), RS1001424591 (9:66987028 G>A,C), RS1003401000 (9:66991830 G>A), RS1003433883 (9:66991242 C>G), RS1004777608 (9:66987895 C>A), RS1005214011 (9:66987503 C>G), RS1005784309 (9:66990345 C>A), RS1005816856 (9:66990196 G>A), RS1006899059 (9:66990862 C>T), RS1007874326 (9:66993964 T>G), RS1007905375 (9:66993626 T>C), RS1007936409 (9:66992899 G>A), RS1010188769 (9:66989665 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, increases methylation | 2 |
| benzo(e)pyrene | increases methylation | 1 |
| aflatoxin B2 | increases methylation | 1 |
| Methapyrilene | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.